During the past decade, Mid-Ohio Behavioral Health conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mid-Ohio Behavioral Health" are "Attention-Deficit/Hyperactivity Disorder" (1 trials) and "Schizophrenia" (1 trials). Many other conditions were trialed in "Mid-Ohio Behavioral Health" in a lesser frequency.

Most popular intervention types in "Mid-Ohio Behavioral Health" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Adhansia XR" (1 trials), "Concerta" (1 trials) and "Xanomeline and Trospium Chloride Capsules" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mid-Ohio Behavioral Health" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mid-Ohio Behavioral Health". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mid-Ohio Behavioral Health, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mid-Ohio Behavioral Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".